Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACE phase 3 trial of intramuscular PLX-PAD for no-option critical limb ischemia
MOH_2018-07-08_002430Phase 3Completed
- Sponsor
- Pluri Inc.
- Start
- May 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic limb-threatening ischemia (CLTI) comparing Standard treatment + PLX-PAD with Standard treatment + placebo (2 arms). Started May 2018; status: completed.
02
Drugs
PLX-PAD
03
Conditions
chronic limb-threatening ischemia (CLTI)
Beyond the preview
Go deeper on MOH_2018-07-08_002430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-07-08_002430.